Sat, Nov 29, 2014, 5:31 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Navidea Biopharmaceuticals, Inc Message Board

  • ontopofitall4u ontopofitall4u Mar 16, 2013 8:50 PM Flag

    Just imagine how JP morgan feels about their stock purchase at $3.05

    Did they n ot pick up shares in anticipation of approval at $3.05?
    Maybe they dumped their shares in the $3.50 range. I seriously doubt they have sold any shares. They may have bought more. This stock has been manipulated past a SEC investigation. The shorts have complete control and will let it go when they have covered and gonwe long. They just had too much power.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Exactly, they are in command and control for this stock. They have already ruined this stock and will not leave it alone. But the matter of fact they are not alone. Management provided opportunities and there must be some insider in them providing this info to shorts and they get set ready to attack it. I know I don't have any proof for that but the price action speaks for itself. As I said before, if 25 cents decline everyday, then under $2 in few 3-4 days.

      • 1 Reply to fincheck100
      • biz journal has an article out about how NAVB is one of the most highly shorted stocks. WBB's brozak stated that the shorts are fighting for their lives. doesnt seem that they are having to put up much of a fight. i know the game is rigged, always has been always will be, but i cant understand the mm's bringing NAVB below pre earnings price. it makes me wonder if there is something else that we are missing. some will be lucky enough to get in at the lows and make out very well. for me i will be watching the technicals for a momentum change before i add. good luck fellow investors.

 
NAVB
1.24-0.02(-1.59%)Nov 28 1:04 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.